← Open Payments lookup

SUMMER MILLER: Open Payments

NPI 1831829167 · BRANDON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,099 in 121 payments from 13 companies in 2025. Trend: 2023 $1,665 · 2024 $1,678 · 2025 $2,099

Food & beverage: $2,099
CompanyPaymentsAmount
ABBVIE INC.22$345
Lundbeck LLC22$324
Otsuka America Pharmaceutical, Inc.15$183
Alkermes, Inc.8$179
E.R. Squibb & Sons, L.L.C.8$171
Janssen Pharmaceuticals, Inc8$151
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$142
Teva Pharmaceuticals USA, Inc.7$136
Neurocrine BioSciences, Inc.7$135
Tris Pharma Inc7$131

Products named: VRAYLAR, ABILIFY ASIMTUFII, COBENFY, REXULTI, ARISTADA, INVEGA SUSTENNA, CAPLYTA, INGREZZA.

Industry payments across MS — which companies pay providers there.